CPHI Middle East 2026 | 11-13 May, Riyadh

Why It Matters

The conference offers a rare platform for global pharma companies to penetrate the fast‑growing Middle Eastern market, accelerating partnerships and regulatory alignment. Its scale can influence regional investment flows and supply‑chain strategies.

Key Takeaways

• 30,000+ visitors attended 2024 edition.
• Over 100 countries represented at prior event.
• 2026 show emphasizes regulatory and innovation insights.
• Direct market access for global pharma firms.

Pulse Analysis

The Middle East has emerged as a strategic frontier for pharmaceutical expansion, driven by rising healthcare expenditures, a youthful population, and government initiatives such as Saudi Vision 2030. CPHI Middle East, scheduled for 11‑13 May 2026 in Riyadh, capitalises on this momentum by convening the region’s most influential buyers, manufacturers, and regulators under one roof. Following a breakout 2024 edition that drew more than 30,000 delegates from over 100 nations, the 2026 event is poised to become the premier marketplace for new product launches, technology transfers, and cross‑border collaborations.

Beyond exhibition space, the conference delivers deep‑dive sessions on evolving regulatory frameworks, including recent Saudi Food and Drug Authority guidelines and GCC harmonisation efforts. Attendees can tap into real‑time intelligence on biosimilar pathways, digital health approvals, and advanced manufacturing standards. For biotech and med‑tech firms, the platform offers direct access to decision‑makers who control procurement budgets and distribution networks, shortening the sales cycle and reducing reliance on intermediaries. Networking lounges and matchmaking tools further streamline partnership formation, fostering joint ventures and licensing agreements.

The comprehensive supply‑chain showcase will feature everything from raw‑material sourcing to packaging automation, reflecting the industry's push toward end‑to‑end visibility and resilience. With sustainability and traceability becoming contractual requirements, exhibitors can demonstrate compliance solutions that meet both local mandates and global best practices. As the region accelerates its shift from import‑dependence to domestic production, participants who secure early footholds stand to capture significant market share. Consequently, CPHI Middle East 2026 is not merely a trade fair—it is a catalyst for long‑term growth in a high‑potential market.